Is Busulfan Clearance Different in Patients With Sickle Cell Disease? Let’s Clear Up That Case With Some Controls

Autor: Niina Kleiber, Henrique Bittencourt, Amandine Remy, Thierry Ducruet, Yves D. Pastore, Yves Théorêt, Marc Ansari, Maja Krajinovic, Tiago Nava, Mohamed Aziz Rezgui

Publikováno v: Journal of pediatric hematology/oncology, Vol. 43, No 6 (2021) pp. e867-e872

In busulfan-based conditioning regimen for hematopoietic stem cell transplantation in children, accurate a priori determination of the first dose is important because of its narrow therapeutic window. Sickle cell disease (SCD) influences pharmacokine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d39c906eab54364c1dae59520ff41d4
https://doi.org/10.1097/mph.0000000000002106

Fate of undifferentiated mouse embryonic stem cells within the rat heart: role of myocardial infarction and immune suppression

Autor: Afksendyios Kalangos, François Herrmann, Qing He, Marisa Jaconi, Michel Dubois-Dauphin, Esther Bettiol, Pedro T. Trindade, Michael Stumm, Jian Li, Denis R. Morel, Prisca Zammaretti

Publikováno v: Journal of Cellular and Molecular Medicine
Journal of Cellular and Molecular Medicine, Vol. 13, No 1 (2009) pp. 188-201

It has recently been suggested that the infarcted rat heart microenvironment could direct pluripotent mouse embryonic stem cells to differentiate into cardiomyocytes through an in situ paracrine action. To investigate whether the heart can function a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4df9ca1dec7a66a6579122be9fff18f1
https://doi.org/10.1111/j.1582-4934.2008.00323.x